Zhimeng Biopharma Receives CDE Approval to Advance CB03-154 into Phase 2/3 Trials for ALS in China

Shanghai Zhimeng Biopharma, Inc. ("Zhimeng Biopharma"), a clinical-stage biopharmaceutical company dedicated to innovative drug development for liver and...

July 10, 2025 | Thursday | News
Purespring Therapeutics Receives FDA Clearance to Initiate Clinical Trials for IgA Nephropathy Gene Therapy

Purespring Therapeutics, a precision nephrology company focused on transforming the treatment of kidney diseases, announces that the U.S. Food and Drug A...

July 10, 2025 | Thursday | News
Amarna Therapeutics and NorthX Biologics Advance Gene Therapy Manufacturing for Type 1 Diabetes

Amarna Therapeutics, (“Amarna” or “the Company”), a privately held biotechnology company pioneering transformative gene therapies...

July 09, 2025 | Wednesday | News
Abinopharm Reports Positive Clinical Trial Outcomes for Oral Dr.Ergo® L-Ergothioneine in Enhancing Skin Health

Abinopharm, Inc., an innovative nutritional and biopharmaceutical company based in Shelton, Connecticut, USA, is pleased to announce that its partner, EG...

July 07, 2025 | Monday | News
MaaT Pharma and Clinigen Sign Exclusive European Licensing Deal for Xervyteg® in Acute Graft-Versus-Host Disease

MaaT Pharma and Clinigen signed exclusive long-term licensing and distribution agreement and commercial supply agreement for Xervyteg® (MaaT013),...

July 03, 2025 | Thursday | News
Alvotech and Advanz Pharma Forge Agreement to Commercialise Biosimilar Candidate to Cimzia® Across Europe

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Adva...

July 02, 2025 | Wednesday | News
HUTCHMED and AstraZeneca Secure China Approval for ORPATHYS®–TAGRISSO® Combination in EGFR-Mutant NSCLC with MET Amplification

HUTCHMED (China) Limited  announces that the New Drug Application (“NDA”) for the combination of ORPATHYS® (savolitinib) and TAGRISS...

July 01, 2025 | Tuesday | News
Mabion and NovalGen Forge Strategic Partnership to Advance First-in-Class T-Cell Engager NVG-222 Into Clinical Trials

In a significant move to accelerate the global fight against blood cancers and hard-totreat solid tumours, renowned end- to-end biologics CDMO Mabion hav...

June 30, 2025 | Monday | News
ProBio Opens Flagship Cell and Gene Therapy Center of Excellence in New Jersey, Advancing Global Biomanufacturing Capabilities

ProBio, a global contract development and manufacturing organization (CDMO) specializing in cell and gene therapy, today announced the opening of its...

June 27, 2025 | Friday | News
MGI Tech and Negedia Join Forces to Expand Access to Spatial Transcriptomics and Precision Genomics in Italy

MGI Tech Co., Ltd. (MGI), a company dedicated to developing core tools and technologies that drive innovation in life sciences, today announced a pa...

June 27, 2025 | Friday | News
EXACT Therapeutics Doses First Patient in Phase 2 ENACT Trial for Pancreatic Cancer

EXACT Therapeutics (Euronext Growth: EXTX), a clinical-stage precision medicine company, is pleased to announce first patient dosed in its ENACT trial. ...

June 24, 2025 | Tuesday | News
Alvotech and Advanz Pharma Receive CHMP Positive Opinion for AVT06, a Proposed Biosimilar to Eylea®

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Adva...

June 24, 2025 | Tuesday | News
Perceptive Discovery Launches FIBRE Consortium with Pfizer, Lantheus, and Lumina to Advance Imaging Biomarkers in Fibrotic Diseases

Perceptive Discovery, a global leader in molecular and functional imaging research, today announced the launch of the FIBRE (Fibrosis Imaging Biomarker R...

June 23, 2025 | Monday | News
Yale School of Medicine Launches Biomedical Imaging Institute to Drive Innovation in Health and Disease Research

Yale School of Medicine (YSM) announces the launch of the Yale Biomedical Imaging Institute, a cross-disciplinary hub that will unite leading experts in ...

June 23, 2025 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close